Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies

Haematologica

Volumn 89, Issue 1, 2004, Pages 11-20

  Clarke, Alan A ^a   Gibson, Frances M ^a   Scott, Julie ^a   Myatt, Nyree ^a   Rutherford, Tim R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Fanconi's anemia; Fas; Mitochondria; Mitomycin C

Indexed keywords

COMPLEMENTARY DNA; DNA; FAS ANTIBODY; MITOMYCIN C;

ANEMIA; APOPTOSIS; ARTICLE; CELL DEATH; FANCONI ANEMIA; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MITOCHONDRION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; JURKAT CELLS; LYMPHOCYTES; MALE; MITOCHONDRIA; MITOMYCIN; NUCLEAR PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; TUMOR CELLS, CULTURED;

EID: 0842328533     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-6.
2. Schroeder-Kurth TM, Auerbach AD. Fanconi Anemia: Clinical, Cytogenetic and Experimental Aspects. New York: Springer-Verlag, 1989.
3. Clarke AA, Marsh JC, Gordon-Smith EC, Rutherford TR. Molecular genetics and Fanconi anaemia: new insights into old problems. Br J Haematol 1998;103:287-96.
4. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003;3:23-34.
5. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297:606-9.
6. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 1994;91:7975-9.
7. Hoatlin ME, Christianson TA, Keeble WW, Hammond AT, Zhi Y, Heinrich MC, et al. The Fanconi Anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood 1998;91:1418-25.
8. de Winter JP, van der WL, de Groot J, Stone S, Waisfisz Q, Arwert F, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 2000;9:2665-74.
9. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002;100:2414-20.
10. Kupter GM, Yamashita T, Naf D, Suliman A, Asano S, D'Andrea AD. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 1997;90:1047-54.
11. Hoshino T, Youssoufian H, Wang J. The molecular chaperone GRP94 binds to a central domain within the group C Fanconi anemia protein. Blood 1996;88 Suppl 1:48a[abstract].
12. Pang Q, Christianson TA, Keeble W, Koretsky T, Bagby GC. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J Biol Chem 2002;277:49638-43.
13. Youssoufian H, Hoshino T, Liu JM, Joseph P, Jaiswal AK. Binding of the Fanconi anemia group C protein to NADPH cytochrome P-450 reductase: Implications for mitomycin C activation. Blood 1997;90:438a[abstract].
14. Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001;7:814-20.
15. Pang Q, Fagerlie S, Christianson TA, Keeble W, Faulkner G, Diaz J, et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by γ interferon and hematopoietic growth factors. Mol Cell Biol 2000;20:4724-35.
16. Otsuki T, Young DB, Sasaki DT, Pando MP, Li J, Manning A, et al. Fanconi anemia protein complex is a novel target of the IKK signalsome. J Cell Biochem 2002;86:613-23.
17. Futaki M, Watanabe S, Tatsuguchi A, Igarashi T, Kajigaya S. Translocation of FANCG to endoplasmic reticulum and mitochondria after exposure to mitomycin C. Blood 2000;16:229a[abstract].
18. Futaki M, Igarashi T, Watanabe S, Kajigaya S, Tatsuguchi A, Wang J, et al. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 2002;23:67-72.
19. Clarke AA, Philpott NJ, Gordon-Smith EC, Rutherford TR. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 1997;96:240-7.
20. Guillouf C, Wang TS, Liu J, Walsh CE, Poirier GG, Moustacchi E, et al. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death. Exp Cell Res 1999;246:384-94.
21. Pritsos CA, Briggs LA, Gustafson DL. A new cellular target for mitomycin C: a case for mitochondrial DNA. Oncol Res 1997;9:333-7.
22. Bachur NR, Gordon SL, Gee MV, Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 1979;76:954-7.
23. Tomasz M. H2O2 generation during the redox cycle of mitomycin C and DNA-bound mitomycin C. Chem Biol Interact 1976;13:89-97.
24. Pritsos CA, Sartorelli AC. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986;46:3528-32.
25. Bogliolo M, Borghini S, Abbondandolo A, Degan P. Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia. Mutagenesis 2002;17:25-30.
26. Ruppitsch W, Meisslitzer C, Weirich-Schwaiger H, Klocker H, Scheidereit C, Schweiger M, et al. The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Hum Genet 1997;99:710-9.
27. Paulin-Levasseur M, Chen G, Lariviere C. The 2G2 antibody recognizes an acidic 110-kDa human mitochondrial protein. Histochem J 1998;30:617-25.
28. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003;10:26-35.
29. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992;358:434.
30. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 1996;14:320-3.
31. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994;170:145-57.
32. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 1991;88:3671-5.
33. Newell MK, Haughn U, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990;347:286-9.
34. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 1972;26:239-57.
35. Cumming RC, Liu JM, Youssoufian H, Buchwald M, Jacobson MD. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene Reactive oxygen species and programmed cell death. Blood 1996;88:4558-67.
36. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001;2:589-98.
37. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998;102-103:139-42.
38. Philpott NJ, Turner AJ, Scopes J, Westby M, Marsh JC, Gordon-Smith EC, et al. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 1996;87:2244-51.
39. Ridet A, Guillouf C, Duchaud E, Cundari E, Fiore M, Moustacchi E, et al. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 1997;57:1722-30.
40. Gille JJ, Wortelboer HM, Joenje H. Antioxidant status of Fanconi anemia fibroblasts. Hum Genet 1987;77:28-31.
41. Degan P, Bonassi S, De Caterina M, Korkina LG, Pinto L, Scopacasa F, et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995;16:735-41.
42. Clement MV, Stamenkovic I. Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J 1996;15:216-25.
43. Wang J, Otsuki T, Youssoufian H, Foe JL, Kim S, Devetten M, Yu J, et al. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. Cancer Res 1998;58:3538-41.
44. Rathbun RK, Faulkner GR, Ostroski MH, et Christianson TA, Hughes G, Jones G, al. Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells. Blood 1997;90:974-85.
45. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
46. Volbracht C, Leist M, Kolb SA, Nicotera P. Apoptosis in caspase-inhibited neurons. Mol Med 2001;7:36-48.
47. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998;188:919-30.
48. Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998;273:9357-9360.
49. Duriez PJ, Shah GM. Cleavage of poly-(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 1997;75:337-49.
50. Klocker H, Auer B, Hirsch-Kauffmann M, Altmann H, Burtscher HJ, Schweiger M. DNA repair dependent NAD+ metabolism is impaired in cells from patients with Fanconi's anemia. EMBO J 1983;2:303-7.
51. Durkacz BW, Omidiji O, Gray DA, Shall S. (ADP-ribose)n participates in DNA excision repair. Nature 1980;283:593-6.
52. Spronck JC, Kirkland JB. Niacin deficiency increases spontaneous and etoposide-induced chromosomal instability in rat bone marrow cells in vivo. Mutat Res 2002;508:83-97.